Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about boron technology
Pipeline

By exploiting the advantages of our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

 
Pipeline Graphic
 
 
New Releases

July 29, 2010 | GSK Exercises Option On Anacor's Novel Antibiotic For The Treatment Of Gram-Negative Infections
June 15, 2010 | AN3365, A Novel Antibiotic Intended to Treat Infections Caused by Gram-Negative Bacteria, Completes Phase 1 Trial and Achieves Proof of Concept in Collaboration with GSK
June 15, 2010 | Anacor Announces Phase 2b Top-Line Results For AN2728 In Psoriasis
 
New Releases Graphic
 
 
Pipeline

Current Job Opportunities


[ View all jobs ]


 
 

Neglected Diseases